Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for October 6, 2004 Subscribe to this News Feed      
 

Breakthrough Clinical Study Published For the Pain Treatment of Osteoarthritis

A non-invasive modality using a patented form of bioelectricity is clinically proven as having long term effects in the treatment of osteoarthritis with out any negative side effects. No other treatment including pharmaceuticals has been able to show any significant long term effects. The modality is currently available to and being used by physicians in the United States.

(PRWEB) October 6, 2004 -- A new clinical study in Osteoarthritis using Hako-Meds patented Horizontal Therapy was one of three research papers on Horizontal Therapy published two weeks ago at the national annual congress of the Italian Society of Physical Medicine and Rehabilitation in Italy. This latest clinical data demonstrates long-term effects unprecedented with any treatment option for Osteoarthritis.

After approximately ten treatments one hundred percent of the two hundred subjects in the study had completely discontinued their pain medications. Follow-up at three and six months without further Horizontal Therapy treatments demonstrated a significant percentage of subjects who have not reverted to using medications.

Horizontal Therapy is a noninvasive pleasant treatment without any negative side effects. Positive therapeutic results in up to ninety percent of all patients are immediate, significant and cumulative.

Horizontal Therapy is currently available in the United States from a variety of physician specialties. Hako-Med possesses market clearance for pain as well as other indications.

Horizontal Therapy uses a specialized patented form of bioelectricity different from conventional Electromedicine which presents Horizontal Therapy as a viable alternative to potentially dangerous pharmaceuticals in the treatment of pain.

For more information, additional clinical papers, available translations and/or interview requests please contact Kai Hansjürgens at 1-888-913-7900 ext 21.

# # #

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Kai Hansjurgens
HAKO-MED
866-269-7900
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright